跳至主要内容
临床试验/NCT05809284
NCT05809284招募中不适用

Determining the Mechanisms of Loss of CAR T Cell Persistence

University College, London3 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年10月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
3
主要终点
Time to circulating CAR-T cell loss

研究概览

简要总结

A prospective observational study of pediatric and young adult acute lymphoblastic leukaemia (ALL) patients treated with CD19 chimeric antigen receptor T-cells (CAR-T cells). The study will examine changes in CAR-T persistence over time and causal factors.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 25 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Children and young adults (age 25 years or younger) with relapsed/refractory ALL who are planned to receive licensed CD19-targeted CAR-T cell treatment (Tisagenlecleucel)
  • •Written informed consent

排除标准

  • •Patients receiving an alternate CD19-directed CAR T-cell product on a clinical trial
  • •Any reason that in the opinion of the investigator, patients won't be able to adhere to the protocol

结局指标

主要结局

Time to circulating CAR-T cell loss

时间窗: Through study completion, until the last patient reaches 1 year post-infusion

CAR-T persistence will be measured in the central lab from blood samples.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验